Wayne Feng, MD, MS, FANA
Duke University School of Medicine
Dr. Wayne Feng is the Chief of the Division of Stroke & Vascular Neurology and the Medical Director of the Duke Comprehensive Stroke Center. He is also a tenured Professor of Neurology and Biomedical Engineering at the Duke University School of Medicine. Dr. Feng is a board-certified vascular neurologist and physician-scientist.
His research portfolio includes the development of imaging biomarkers to predict post-stroke motor outcomes and the use of non-invasive brain stimulation tools—such as transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), low-intensity focused ultrasound stimulation (LIFUS), and transcranial magnetic stimulation (TMS)—to enhance post-stroke recovery and reduce post-stroke disabilities.
Dr. Feng served as the lead Principal Investigator for the recently completed NIH-funded TRANSPORT2 trial (TRANScranial Direct Current Stimulation for Post-Stroke Motor Recovery), a phase II study conducted through the NINDS-funded Stroke Trial Network. The results were recently published in The Lancet Neurology.
He has authored over 160 peer-reviewed manuscripts (with an h-index of 46), published in leading journals such as Annals of Neurology, The Lancet Neurology, and The Lancet. Two of his manuscripts were featured on the cover of Brain Stimulation. He also holds several intellectual property rights related to ultrasound stimulation, which are currently in the process of being licensed.
Dr. Feng co-edited the book Cerebral Venous System in Acute and Chronic Brain Injuries and served as Associate Editor for Translational Stroke Research (Impact Factor 7.0) from 2019 to 2021.
He has received multiple prestigious awards for his work in stroke and stroke recovery, including the inaugural “Stroke Rehabilitation Award” from the American Heart Association, the “Franz Gerstenbrand Award” from the World Federation of Neurorehabilitation (WFNR), the Arthur Guyton New Investigator Award from the Consortium for Southeastern Hypertension Control (COSEHC), and the “Clinical Investigator Award” from the Society of Chinese American Physician Entrepreneurs (SCAPE).
Currently, Dr. Feng serves as Section Chair of Neural Repair & Rehabilitation at the American Academy of Neurology, an At-Large Member of the World Federation of Neurorehabilitation, and the global mentoring program lead for WFNR. He is also the training director for the NIH StrokeNet Recovery Fellow Cohort.